By Karen Blum
COVID-19 forced the hepatitis C virus (HCV) prior authorization (PA) team at the University of Illinois Hospital and Health Sciences System to redesign its workflow to accommodate working from home.
Previous generations of the PA team worked on-site at the medical center, where they could easily ask questions of Michelle T. Martin, PharmD, a clinical pharmacist for the health system and an associate professor at the Universi-ty of Illinois College of Pharmacy, both in Chicago.